lutetium lu 177 vipivotide tetraxetan,cabazitaxel
emcure,sanofi,novartis
['crpc', 'therap ']
 w/ #therap updates, incl os. no difference in os, although confounded by subsequent treatments. much worse os in psma/fdg pet discordant screen failure pts, implying distinct biology of psma-low or -heterogenous mcrpc. can combos or alphas overcome? #psma #asco22 
Asst Professor/Physician-Scientist (MD PhD): GU Oncology & Phase 1 @weillcornell @WCMEnglanderIPM @nyphospital Alum @swarthmore @IowaMed #prostatecancer #GoCubs